• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMalaria

Malaria

malaria no more
CommentaryMalaria isn’t just a health crisis — it’s an economic imperative
By Martin Edlund and Florizelle LiserNovember 7, 2025
HealthSwitzerland approves first antimalarial drug for infants in advance on disease that kills hundreds of thousands in Africa each year
By Jamey Keaten and The Associated PressJuly 9, 2025
HealthOver 14 million people could die from Trump administration cuts to U.S. foreign aid, study finds
By Daniel Lawler and AFPJuly 1, 2025
HealthInside Bill Gates’ meeting with his foundation’s staff after his $200 billion bombshell: ‘How do we get people to care?’
By Alexa MikhailMay 28, 2025
Closeup of an eye looking at a mosquito on a leaf in foreground
HealthEEE, West Nile, malaria: Know the difference between these mosquito-borne diseases
By The Associated PressAugust 27, 2024
HealthCases of West Nile virus—and even malaria—are on the rise in the U.S. How to protect yourself from mosquito-borne illness this summer
By Erin PraterJuly 1, 2023
Brad DeLong
NewslettersWhy economist Brad DeLong says leaders should be open to the process of creative destruction
By David Meyer and Alan MurraySeptember 8, 2022
HealthWorld Health Organization backs first Malaria vaccine for at-risk children
By James Paton, Joel Leon and BloombergOctober 6, 2021
HealthBioNTech plans on developing a vaccine that prevents Malaria
By Naomi Kresge and BloombergJuly 26, 2021
Vials of AstraZeneca's Covid-19 vaccine.
HealthWith AstraZeneca’s COVID-19 vaccine trials on hold in the U.S., a gulf widens between America and other countries
By Jeremy KahnOctober 2, 2020
Hydroxychloroquine study shows deaths, heart risks in COVID-19 patients
HealthHydroxychloroquine linked to deaths and heart risks in new COVID-19 study after Trump touted and claimed to be taking the drug
By John Lauerman and BloombergMay 22, 2020
Normally used to treat malaria, hydroxychloroquine yielded promising yet inconclusive results in a small coronavirus trial. While Trump has said the drug is safe, it carries significant side effects.
HealthIndia eases malaria drug export ban after Trump call for supply to fight coronavirus
By Archana Chaudhary and BloombergApril 7, 2020
LONDON, UNITED KINGDOM - MARCH 26: In this photo illustration a pack of Hydroxychloroquine Sulfate medication is displayed on March 26, 2020 in London, United Kingdom. The Coronavirus (COVID-19) pandemic has spread to many countries across the world, claiming over 20,000 lives and infecting hundreds of thousands more. U.S. President Donald Trump recently promoted Hydroxychloroquine, a common anti-malaria drug, as a potential treatment for COVID-19 when combined with the antibiotic azithromycin. “HYDROXYCHLOROQUINE & AZITHROMYCIN, taken together, have a real chance to be one of the biggest game changers in the history of medicine,” President Trump tweeted last week. (Photo by John Phillips/Getty Images)
HealthMalaria drug Trump touted as coronavirus treatment has been given FDA emergency authorization
By John Lauerman and BloombergMarch 30, 2020
Employees work on the production line of chloroquine phosphate, an old drug for the treatment of malaria, in a pharmaceutical company in Nantong city in east China's Jiangsu province Feb. 27, 2020.
HealthMalaria drug touted as coronavirus treatment by Trump and Elon Musk can be deadly, China finds
By BloombergMarch 20, 2020
GHANA-HEALTH-VACCINES-MALARIA
HealthGroundbreaking malaria vaccine test underway in 3 African nations
By Cara Anna, Lauran Neergaard and The Associated PressJanuary 16, 2020
1
  • 1
  • 2
2
Most Popular
Innovation
The U.S. spent $30 billion to ditch textbooks for laptops and tablets: The result is the first generation less cognitively capable than their parentsAn image of a popular article
By Sasha RogelbergFebruary 21, 2026
Economy
New Fed report proves Milton Friedman and Joe Biden understood something vital about immigration—and explains why growth may sputter under TrumpAn image of a popular article
By Shawn TullyFebruary 22, 2026
Startups & Venture
'I have a chip on my shoulder.' Phoebe Gates wants her $185 million AI startup Phia to succeed with 'no ties to my privilege or my last name'An image of a popular article
By Sydney LakeFebruary 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.